Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

UK research reform: get the facts straight.

Borysiewicz LK.

Nature. 2016 Nov 17;539(7629):357. doi: 10.1038/539357c. No abstract available.

PMID:
27853215
2.

Prevention is better than cure.

Borysiewicz LK.

Lancet. 2010 Feb 6;375(9713):513-23. doi: 10.1016/S0140-6736(09)61757-8. Epub 2009 Dec 23. No abstract available.

PMID:
20035989
3.

The global alliance for chronic diseases.

Daar AS, Nabel EG, Pramming SK, Anderson W, Beaudet A, Liu D, Katoch VM, Borysiewicz LK, Glass RI, Bell J.

Science. 2009 Jun 26;324(5935):1642. doi: 10.1126/science.324_1642. No abstract available.

PMID:
19556484
4.

HPV16 E6 29-38-specific T cells kill cervical carcinoma cells despite partial evasion of T-cell effector function.

Thomas KJ, Smith KL, Youde SJ, Evans M, Fiander AN, Borysiewicz LK, Man S.

Int J Cancer. 2008 Jun 15;122(12):2791-9. doi: 10.1002/ijc.23475.

5.

Grand challenges in chronic non-communicable diseases.

Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, Bernstein A, Borysiewicz LK, Colagiuri S, Ganguly N, Glass RI, Finegood DT, Koplan J, Nabel EG, Sarna G, Sarrafzadegan N, Smith R, Yach D, Bell J.

Nature. 2007 Nov 22;450(7169):494-6. No abstract available.

PMID:
18033288
6.

Therapeutic vaccines for cervical cancer: concept and clinical results.

Fiander A, Man S, Borysiewicz LK, Wilkinson GW.

BioDrugs. 1997 Nov;8(5):331-8.

PMID:
18020523
7.

The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.

Prod'homme V, Griffin C, Aicheler RJ, Wang EC, McSharry BP, Rickards CR, Stanton RJ, Borysiewicz LK, López-Botet M, Wilkinson GW, Tomasec P.

J Immunol. 2007 Apr 1;178(7):4473-81.

8.

Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology.

Wall SR, Scherf CF, Morison L, Hart KW, West B, Ekpo G, Fiander AN, Man S, Gelder CM, Walraven G, Borysiewicz LK.

Br J Cancer. 2005 Oct 31;93(9):1068-76.

9.

UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Wang EC, McSharry B, Retiere C, Tomasec P, Williams S, Borysiewicz LK, Braud VM, Wilkinson GW.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7570-5.

10.

T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination.

Vekemans J, Ota MO, Wang EC, Kidd M, Borysiewicz LK, Whittle H, McAdam KP, Morgan G, Marchant A.

Clin Exp Immunol. 2002 Mar;127(3):495-8.

11.

Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells.

Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z.

Blood. 2002 Apr 15;99(8):2913-21.

12.

Requirement for CD28 co-stimulation is lower in SHP-1-deficient T cells.

Sathish JG, Johnson KG, LeRoy FG, Fuller KJ, Hallett MB, Brennan P, Borysiewicz LK, Sims MJ, Matthews RJ.

Eur J Immunol. 2001 Dec;31(12):3649-58.

13.

Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR.

Lawson TM, Man S, Wang EC, Williams S, Amos N, Gillespie GM, Moss PA, Borysiewicz LK.

Int Immunol. 2001 Nov;13(11):1383-90.

PMID:
11675370
14.

Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses.

Lawson TM, Man S, Williams S, Boon AC, Zambon M, Borysiewicz LK.

Int Immunol. 2001 Nov;13(11):1373-81.

PMID:
11675369
15.

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

Evans M, Borysiewicz LK, Evans AS, Rowe M, Jones M, Gileadi U, Cerundolo V, Man S.

J Immunol. 2001 Nov 1;167(9):5420-8.

16.

Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.

Hart KW, Williams OM, Thelwell N, Fiander AN, Brown T, Borysiewicz LK, Gelder CM.

J Clin Microbiol. 2001 Sep;39(9):3204-12.

18.

Training in infectious diseases and tropical medicine in Britain.

Beeching NJ, Borysiewicz LK.

Clin Microbiol Infect. 2000 Aug;6(8):432-4. No abstract available.

19.

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia.

Bontkes HJ, de Gruijl TD, van den Muysenberg AJ, Verheijen RH, Stukart MJ, Meijer CJ, Scheper RJ, Stacey SN, Duggan-Keen MF, Stern PL, Man S, Borysiewicz LK, Walboomers JM.

Int J Cancer. 2000 Oct 1;88(1):92-8.

20.

Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14.

Labéta MO, Vidal K, Nores JE, Arias M, Vita N, Morgan BP, Guillemot JC, Loyaux D, Ferrara P, Schmid D, Affolter M, Borysiewicz LK, Donnet-Hughes A, Schiffrin EJ.

J Exp Med. 2000 May 15;191(10):1807-12.

21.

Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production.

Arias MA, Rey Nores JE, Vita N, Stelter F, Borysiewicz LK, Ferrara P, Labéta MO.

J Immunol. 2000 Apr 1;164(7):3480-6.

22.

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, Gadola S, Cerundolo V, Borysiewicz LK, McMichael AJ, Wilkinson GW.

Science. 2000 Feb 11;287(5455):1031.

23.
24.

TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.

Johnson KG, LeRoy FG, Borysiewicz LK, Matthews RJ.

J Immunol. 1999 Apr 1;162(7):3802-13.

25.

Soluble CD14 acts as a negative regulator of human T cell activation and function.

Rey Nores JE, Bensussan A, Vita N, Stelter F, Arias MA, Jones M, Lefort S, Borysiewicz LK, Ferrara P, Labéta MO.

Eur J Immunol. 1999 Jan;29(1):265-76.

26.

The use of human leucocyte antigen class I transgenic mice to investigate human immune function.

Faulkner L, Borysiewicz LK, Man S.

J Immunol Methods. 1998 Dec 1;221(1-2):1-16. Review.

PMID:
9894893
27.

Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13.

Phillips AJ, Tomasec P, Wang EC, Wilkinson GW, Borysiewicz LK.

Virology. 1998 Oct 25;250(2):350-8.

28.

Vaccinia virus-induced changes in cytokine-regulated acute phase plasma protein synthesis by hepatoma cells.

Rokita H, Branicki W, Wrońska D, Borysiewicz LK, Koj A.

Biochem Mol Biol Int. 1998 May;44(6):1093-104.

PMID:
9623762
29.

Development of a model for cytomegalovirus infection of oligodendrocytes.

Spiller OB, Borysiewicz LK, Morgan BP.

J Gen Virol. 1997 Dec;78 ( Pt 12):3349-56.

PMID:
9400987
30.

Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.

Nimako M, Fiander AN, Wilkinson GW, Borysiewicz LK, Man S.

Cancer Res. 1997 Nov 1;57(21):4855-61.

31.

Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes.

Evans EM, Man S, Evans AS, Borysiewicz LK.

Cancer Res. 1997 Jul 15;57(14):2943-50.

32.

Consequences of live poliovirus vaccine administration in chronic fatigue syndrome.

Vedhara K, Llewelyn MB, Fox JD, Jones M, Jones R, Clements GB, Wang EC, Smith AP, Borysiewicz LK.

J Neuroimmunol. 1997 May;75(1-2):183-95.

PMID:
9143253
33.

Detection and biochemical characteristics of the receptor for complexes of soluble CD14 and bacterial lipopolysaccharide.

Vita N, Lefort S, Sozzani P, Reeb R, Richards S, Borysiewicz LK, Ferrara P, Labéta MO.

J Immunol. 1997 Apr 1;158(7):3457-62.

PMID:
9120307
34.

Grand round--University Hospital of Wales. Focal myositis mimicking acute psoas abscess.

Lawson TM, Borysiewicz LK, Camilleri JP, Jessop JD, Pritchard MH, Williams BD.

BMJ. 1997 Mar 15;314(7083):805-8. No abstract available.

35.

CD8high+ (CD57+) T cells in patients with rheumatoid arthritis.

Wang EC, Lawson TM, Vedhara K, Moss PA, Lehner PJ, Borysiewicz LK.

Arthritis Rheum. 1997 Feb;40(2):237-48.

PMID:
9041935
36.

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

Boursnell ME, Rutherford E, Hickling JK, Rollinson EA, Munro AJ, Rolley N, McLean CS, Borysiewicz LK, Vousden K, Inglis SC.

Vaccine. 1996 Nov;14(16):1485-94.

PMID:
9014288
37.

A malignant astrocytoma in a patient with AIDS: a possible association between astrocytomas and HIV infection.

Neal JW, Llewelyn MB, Morrison HL, Jasani B, Borysiewicz LK.

J Infect. 1996 Nov;33(3):159-62. Review.

PMID:
8945703
38.

Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.

Hopkins JI, Fiander AN, Evans AS, Delchambre M, Gheysen D, Borysiewicz LK.

J Med Virol. 1996 Jun;49(2):124-31.

PMID:
8991935
39.

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

Borysiewicz LK, Fiander A, Nimako M, Man S, Wilkinson GW, Westmoreland D, Evans AS, Adams M, Stacey SN, Boursnell ME, Rutherford E, Hickling JK, Inglis SC.

Lancet. 1996 Jun 1;347(9014):1523-7.

PMID:
8684105
40.

CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus.

Wang EC, Moss PA, Frodsham P, Lehner PJ, Bell JI, Borysiewicz LK.

J Immunol. 1995 Nov 15;155(10):5046-56.

PMID:
7594513
41.

Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients.

Fiander AN, Adams M, Evans AS, Bennett AJ, Borysiewicz LK.

Int J Gynecol Cancer. 1995 Nov;5(6):438-442.

PMID:
11578518
42.

The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections.

Wang EC, Borysiewicz LK.

Scand J Infect Dis Suppl. 1995;99:69-77. Review.

PMID:
8668946
43.

Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment.

Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK.

J Exp Med. 1995 Jan 1;181(1):79-91.

44.

Gene therapy and viral vaccination: the interface.

Wilkinson GW, Borysiewicz LK.

Br Med Bull. 1995 Jan;51(1):205-16. Review.

PMID:
7767644
45.

Lymphocyte culture from endomyocardial biopsies. Effects of polyclonal T cell activators compared with interleukin-2 alone.

Harcombe AA, Cary NR, Mullins P, Sharples LD, Schofield PM, Large SP, Wallwork J, Weissberg PL, Borysiewicz LK.

Transplantation. 1994 Dec 15;58(11):1277-9. No abstract available.

PMID:
7992376
46.

Down-regulation of integrin alpha 1/beta 1 expression and association with cell rounding in human cytomegalovirus-infected fibroblasts.

Warren AP, Owens CN, Borysiewicz LK, Patel K.

J Gen Virol. 1994 Dec;75 ( Pt 12):3319-25.

PMID:
7996126
48.

Hereditary C1q deficiency and systemic lupus erythematosus.

Bowness P, Davies KA, Norsworthy PJ, Athanassiou P, Taylor-Wiedeman J, Borysiewicz LK, Meyer PA, Walport MJ.

QJM. 1994 Aug;87(8):455-64. Review.

PMID:
7922299
50.

Cytotoxic T cells and human herpes virus infections.

Borysiewicz LK, Sissons JG.

Curr Top Microbiol Immunol. 1994;189:123-50. Review. No abstract available.

PMID:
7924434

Supplemental Content

Loading ...
Support Center